About Thomas Johnson
Form D filings for Comanche Biopharma from 2023 to 2024 list Thomas Johnson as chief executive officer and director.
Thomas Johnson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Johnson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Johnson works with at each company, as listed on that company's latest Form D.
Comanche Biopharma Corp. · Form D, Jan 17, 2024
AT
Ann Taylor
Director
BS
Brendan Bulik-Sullivan
Director
MM
Muzammil Mansuri
Director
AA
Allison August
Executive officer
PA
Paul Antinori
Executive officer
AF
Allyson Felix
Director
DG
David Grayzel
Director
SG
Scott Gottlieb
Director
KP
Ketan Patel
Director
MY
Michael Young
Executive officer